David Uprichard, Director at Cyclacel Pharmaceuticals, holds 25.31K shares in Cyclacel Pharmaceuticals (Ticker: CYCC), holds ― shares in Life Technologies Corp (Ticker: ~LIFE). Most recently, David Uprichard ― shares of Cyclacel Pharmaceuticals on ― for an estimated value of ―.

See the Hottest Stocks Based on Insider Trading >

David Uprichard
Cyclacel Pharmaceuticals (CYCC)
Director

Ranked #63,066 out of 78,624 Corporate Insiders

Profitable Transactions

12 out of 52 Profitable Transactions

Average Return

-5.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

CYCC

A breakdown of David Uprichard's holdings

See the Top Stocks by Insiders

Insider Roles

Cyclacel Pharmaceuticals
(CYCC)

Director

Roles that David Uprichard holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Life Technologies Corp
(~LIFE)

Rating:Informative Buy

Date:Feb 04, 2009 - Feb 04, 2010

Return:+31.50%

The most profitable trade made by David Uprichard

See the Latest Stocks Traded by Insiders

David Uprichard's Trading History

CYCC

Cyclacel Pharmaceuticals

―

Director

―

$97.43K

~LIFE

Life Technologies Corp

Feb 04, 2014

―

Uninformative Sell

223.06K

―

List of latest transactions for each holding click on a transaction to see David Uprichard's performance on stock

See All Insider Trading from Today

David Uprichard insider profile FAQ

What is the percentage of profitable transactions made by David Uprichard?

The percentage of profitable transactions made by David Uprichard is 23%.

What is the average return per transaction made by David Uprichard?

The average return per transaction made by David Uprichard is -5.50%.

What stocks does David Uprichard hold?

David Uprichard holds: CYCC, ~LIFE stocks.

What was David Uprichard’s latest transaction?

David Uprichard latest transaction was an Uninformative Buy of ―.

What was David Uprichard's most profitable transaction?

David Uprichard’s most profitable transaction was an Informative Buy of ~LIFE stock on February 4, 2009. The return on the trade was 31.50%.

What is David Uprichard's role in Cyclacel Pharmaceuticals?

David Uprichard's role in Cyclacel Pharmaceuticals is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

David Uprichard Insider Profile

David Uprichard Cyclacel Pharmaceuticals (CYCC)Director